ENLV: Enlivex Therapeutics, Ltd. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Enlivex Therapeutics (ENLV) rivojlanishi joriy operatsion pul oqimi bo'lmagan holda tadqiqot investitsiyalariga asoslangan. PEG koeffitsiyenti qiymat dinamikasini namoyish etadi, bunda 0.00 darajasi joriy holatni aks ettiradi. Enlivex Therapeutics (ENLV) Allocetra ni sinovdan o'tkazish uchun shifoxonalar bilan sinergiya yaratmoqda. Shu bilan birga, sepsis uchun hujayraviy terapiya joriy etilmoqda, bu esa ilmiy risklarni minimallashtiradi va global intensiv terapiya bo'limlariga kirish imkoniyatini ochadi.
Enlivex Therapeutics, Ltd. (ENLV) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Enlivex Therapeutics|ENLV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Enlivex Therapeutics Ltd.|ENLV - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Enlivex Therapeutics|ENLV - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Enlivex Therapeutics|Shoshilinch likvidlik koeffitsiyenti enlivex.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ENLV - Kompaniyaning sof foydasi|Kutilayotgan foyda Enlivex Therapeutics|ENLV - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Enlivex Therapeutics, Ltd.|ENLV - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Enlivex Therapeutics|ENLV - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Enlivex Therapeutics|ENLV - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi enlivex.com|ENLV - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Enlivex Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:ENLV - Enlivex Therapeutics, Ltd.
Enlivex Therapeutics (ENLV) sitokin bo'ronlariga qarshi kurashishning noyob usullarini monetizatsiya qilib, shoshilinch tibbiyot sohasida uzoq muddatli daromadlar oqimini yaratmoqda. PEG koeffitsiyenti joriy P/E ko'rsatkichi bilan kutilayotgan foyda o'sish sur'atini taqqoslaydi. Bir birlikdan past qiymat aktivning kengayishiga nisbatan fundamental past baholanganligidan dalolat beradi. Bu esa yuqori potensialga ega aksiyalarni bozorga chiqishidan oldin aniqlash imkonini beradi. P/E dinamikasini o'sish sur'atlariga nisbatan tahlil qilish orqali investor ushbu innovatsion biznesning bozor qiymati adolatli ekanligini baholaydi.
Raqobatdosh kompaniyalar
ARGX (Argenx) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (biontech.de)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax S.A. (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|Protagonist Therapeutics, Inc. (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant Therapeutics (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori adaptivebiotech.com|Narxning foydaga va o‘sish sur’atiga nisbati Celldex (CLDX)|Aurinia Pharmaceuticals Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (biocryst.com)|Vera Therapeutics, Inc. (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Therapeutics, Inc. - PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tourmaline Corp (TRML)|PGEN (precigen.com) - PEG multiplikatori|PEG multiplikatori Pharming Corp|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Bio Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Zenas Bio ZBIO|IMNM: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharmaceuticals KALV|Septerna (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|pieris.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc) - PEG multiplikatori|RIGL: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ANAB|ATXS (Astria Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Holdings Inc. ENGN|PEG multiplikatori RAPT Therapeutics Inc. RAPT|Aerovate Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Aclaris Therapeutics Inc.|Kyverna (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Tiziana Life Sciences (TLSA)|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio Inc.|Ventyx Biosciences (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori THTX|PEG multiplikatori Avalo Therapeutics Inc. (AVTX)|PEG multiplikatori ELDN (eledon.com)|AGEN - Narx-foyda va o‘sish multiplikatori|CLYM: Narx-foyda va o‘sish multiplikatori|ZURA (Zura Bio Limited) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATYR: PEG multiplikatori|Adagene (ADAG) - PEG multiplikatori|IMA (ikenaoncology.com) - PEG multiplikatori|shattucklabs.com (STTK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Equillium Inc (EQ)|Connect Pharma - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Immunic, Inc. IMUX|ATRA - Narx-foyda va o‘sish multiplikatori|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|XFOR: Narxning foydaga va o‘sish sur’atiga nisbati|ACET: PEG multiplikatori|Celularity Corp (CELU) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio|Barinthus Biotherapeutics plc (BRNS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori KZR|SABS: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AKTX (Akari Therapeutics, Plc)|QTTB - Narx-foyda va o‘sish multiplikatori|geovax.com - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EDSA (Edesa Biotech Inc)|IBIO: PEG multiplikatori|Carisma Tx (CARM) - PEG multiplikatori|XTLB (XTL Biopharmaceuticals) - PEG multiplikatori|BOLT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics, Inc.)|PEG multiplikatori Aptevo (APVO)|PEG multiplikatori AIM (aimimmuno.com)|PEG multiplikatori Aditxt Corp ADTX|GRI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Revelation Bio (REVB) - PEG multiplikatori|INDP (Indaptus Corp) - PEG multiplikatori|SCNI: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori CALI|Narx-foyda va o‘sish multiplikatori Affimed N.V. AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics ITOS|Ocean Biomedical (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|tcbiopharm.com (TCBP) - PEG multiplikatori|THRD (Third Harmonic Bio Inc.) - PEG multiplikatori
